1. Home
  2. PLUS vs OCS Comparison

PLUS vs OCS Comparison

Compare PLUS & OCS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo ePlus inc.

PLUS

ePlus inc.

HOLD

Current Price

$80.41

Market Cap

2.2B

Sector

Technology

ML Signal

HOLD

Logo Oculis Holding AG Ordinary shares

OCS

Oculis Holding AG Ordinary shares

HOLD

Current Price

$11.62

Market Cap

1.8B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
PLUS
OCS
Founded
1990
2003
Country
United States
Switzerland
Employees
N/A
60
Industry
Retail: Computer Software & Peripheral Equipment
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.2B
1.8B
IPO Year
1996
N/A

Fundamental Metrics

Financial Performance
Metric
PLUS
OCS
Price
$80.41
$11.62
Analyst Decision
Strong Buy
Analyst Count
0
6
Target Price
N/A
$42.00
AVG Volume (30 Days)
274.1K
1.1M
Earning Date
05-21-2026
05-07-2026
Dividend Yield
1.20%
N/A
EPS Growth
24.20
N/A
EPS
5.03
N/A
Revenue
$2,442,549,000.00
N/A
Revenue This Year
$19.83
$466.06
Revenue Next Year
$4.36
$479.73
P/E Ratio
$15.75
N/A
Revenue Growth
18.07
N/A
52 Week Low
$62.11
$10.52
52 Week High
$93.98
$34.48

Technical Indicators

Market Signals
Indicator
PLUS
OCS
Relative Strength Index (RSI) 44.13 26.90
Support Level $77.97 $10.52
Resistance Level $90.93 $21.82
Average True Range (ATR) 3.39 0.78
MACD -0.36 0.37
Stochastic Oscillator 34.39 45.56

Price Performance

Historical Comparison
PLUS
OCS

About PLUS ePlus inc.

ePlus Inc is a provider of technology solutions across the IT spectrum, spanning security, cloud, data center, networking, collaboration, AI, service provider, and critical infrastructure, and emerging solutions, to domestic and foreign organizations across all industry segments. Its solutions leverage a broad range of professional, consultative, and managed services across the technology spectrum. The company possesses top-level engineering certifications with a broad range of IT technologies that enable the company to offer multi-vendor IT solutions that are optimized for each of its customers' specific requirements. It also offers a wide portfolio of technology and other capital asset financing solutions to customers across commercial and government enterprises, designing programs.

About OCS Oculis Holding AG Ordinary shares

Oculis Holding AG is a biopharmaceutical company purposefully driven to save sight and improve eye care. It includes OCS-01, a topical retinal candidate for diabetic macular edema (DME); OCS-02, a topical biologic candidate for dry eye disease (DED); and OCS-05, a disease modifying candidate for acute optic neuritis (AON) and other neuro-ophtha disorders such as glaucoma, diabetic retinopathy, geographic atrophy, and neurotrophic keratitis. The Company has locations in five countries: Switzerland, Iceland, France, U.S. and Hong Kong.

Share on Social Networks: